Comparator: Gardasil

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Cervical CancerGenital WartsHPVHuman Papillomavirus InfectionPremalignancy Anogenital WartsVaginal CancerVulvar Cancer

Phase 2

Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

CompletedNCT00260039

Merck Sharp & Dohme LLCCervical Cancer, HPV, Premalignancy Anogenital Warts

Start: 2005-12-31End: 2007-08-31Updated: 2015-06-08

Phase 3

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

CompletedNCT00543543

Merck Sharp & Dohme LLCCervical Cancer, Genital Warts, Human Papillomavirus Infection +2

Start: 2007-09-24End: 2016-07-07Updated: 2018-11-27

Related Papers

Effect of Prior 9-Valent Human Papillomavirus Vaccination on Subsequent Lower Genital Tract Dysplasia After Cervical Excisional Surgery.

2025-10-301 citations

Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies

Human Vaccines & Immunotherapeutics2025-01-223 citations

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

Human Vaccines & Immunotherapeutics2020-12-1648 citations

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

Gynecologic Oncology2019-04-1190 citations

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries

The Journal of Infectious Diseases2018-03-0748 citations

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.

2017-09-05311 citations

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.

2017-08-0531 citations

Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine

Human Vaccines & Immunotherapeutics2015-04-2737 citations

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

New England Journal of Medicine2015-02-181382 citations